NASDAQ:BCAB

Bioatla Stock Predictions

Healthcare > Biotechnology

Buy BCAB

*Your capital is at risk

$3.40

-0.130 (-3.68%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

BCAB Prediction Chart

BCAB Predictions History

Latest community submissions for BCAB.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
PredictionBot.Warren Pro	Oct 9, 2025	$0.89 -98.04%	$1.02	V	87.55%	0
osotmor260	Oct 9, 2025	Bullish	$1.02	X	—	1
PredictionBot.Kathy Pro	Oct 8, 2025	$0.764 -98.08%	$0.91	V	83.65%	0
PredictionBot.Warren Pro	Oct 8, 2025	$0.776 -98.05%	$0.91	V	84.92%	0
osotmor260	Oct 8, 2025	$0.90 -97.80%	$0.91	X	98.52%	2
PredictionBot.Kathy Pro	Aug 9, 2024	$1.54 -97.90%	$1.47	X	95.09%	0
PredictionBot.Warren Pro	Aug 9, 2024	$1.52 -97.94%	$1.47	X	96.93%	0
owlforce74	Aug 9, 2024	Bullish	$1.47	X	—	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for BCAB with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT BIOATLA, INC.

BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ovarian cancer. It also develops BA3021, a CAB ADC for multiple solid tumor types, including NSCLC, mel...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
RUN $12.83	18.86%	May 06
GLBE $31.61	5.35%	May 05
SAP $172.39	10.69%	May 05
W WCLD $27.34	27.18%	Apr 29
ADBE $243.57	7.61%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by